The Use of Neutrophil Gelatinase Associated Lipocalin (NGAL) As A Novel Marker in Early Diagnosis of Hepatorenal Syndrome in Advanced Cirrhotic Patients

STUDY OF URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) IN PATIENTS WITH LIVER CIRRHOSIS AND ITS RELATION TO HEPATORENAL SYNDROME

Urinary Neutrophil Gelatinase Associated lipocalin (NGAL) as A Biomarker of Acute Kidney Injury in Patients with Liver Cirrhosis

URINARY NEUOTROPHIL GELATINASE ASSOCIATED LIPOCALIN AS A DIAGNOSTIC AND A PROGNOSTIC MARKER FOR RENAL INSULT IN CIRRHOTIC PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITIS

Impact of NGAL (Neutrophil Gelatinase Associated lipocalin) on Outcome of Hepato-renal Syndrome

Neutrophil gelatinase-associated lipocalin (NGAL) role in diagnosis of complications of liver cirrhosis

NEUTROPHIL GELATINASE–ASSOCIATED LIPOCALIN (NGAL) AS AN EARLY BIOMARKER OF ACUTE KIDNEY INJURY IN HEPATIC PATIENTS

Interleukin-18 as a Urinary Biomarker for Diagnosis of Hepatorenal Syndrome in Patients with Decompensated Liver Cirrhosis

CHILD-TURCOTTE-PUGH /ALBUMINURIA AS A PREDICTOR OF ACUTE KIDNEY INJURY AMONG HOSPITALIZED PATIENTS WITH LIVER CIRRHOSIS

Urine Albumin Creatinine Ratio as a Predictor of Acute Kidney Injury in Cirrhotic Patient with Hepatic Encephalopathy